In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Christoph Saely
Christoph Saely Christoph Saely

VIVIT Institute, Feldkirch (Austria)

Specialities : Rehabilitation and Sports Cardiology , Coronary Artery Disease Chronic

22 presentations from this speaker

Diabetes: another breakthrough in prevention.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : The year in preventive cardiology
  • Speaker : CH Saely (Feldkirch,AT)
  • Joint session with the European Heart Journal and the European Journal of Preventive Cardiology.

PCSK9-Inhibitions: for whom, when, and how effective.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Secondary Prevention: unmet medical needs - Session I
  • Speaker : CH Saely (Feldkirch,AT)

Serum uromodulin predicts a decline in kidney function independently from the presence of type 2 diabetes

Event : ESC Congress 2017

  • Session : Risk estimation in high risk individuals
  • Speaker : CH Saely (Feldkirch,AT)

Serum uromodulin predicts mortality independently from the presence of type 2 diabetes

Event : ESC Congress 2017

  • Session : Prevention general
  • Speaker : CH Saely (Feldkirch,AT)

Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease

Event : ESC Congress 2017

  • Session : Adverse outcome in patients with cardiometabolic disorders
  • Speaker : CH Saely (Feldkirch,AT)

Remnant cholesterol predicts cardiovascular event risk in patients with type 2 diabetes independently from the baseline coronary artery disease state

Event : ESC Congress 2015

  • Session : Effect of different risk factors on the cardiovascular system
  • Speaker : CH Saely (Feldkirch,AT)

Body mass index significantly modulates the power of C-reactive protein to predict cardiovascular event risk among angiographied coronary patients

Event : ESC Congress 2014

  • Session : Biomarkers: Inflammation, oxidative stress and vascular function
  • Speaker : CH Saely (Feldkirch,AT)

Plasma chemerin is a strong and independent predictor of cardiovascular event risk

Event : ESC Congress 2014

  • Session : Novel biomarkers in predicting cardiovascular diseases
  • Speaker : CH Saely (Feldkirch,AT)

Lipoprotein (a), the metabolic syndrome and vascular risk in angiographied coronary patients

Event : ESC Congress 2013

  • Session : Cardiovascular risk revisited
  • Speaker : CH Saely (Feldkirch,AT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are